| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/24/2011 | US20110047634 Methods and compositions for the diagnosis and treatment of acute lymphoblastic leukemia |
| 02/24/2011 | US20110046891 CO-CRYSTALLIZATION OF ERR-alpha WITH A LIGAND THAT FORMS A REVERSIBLE COVALENT BOND |
| 02/24/2011 | US20110046356 Post-translational modifications and clostridial neurotoxins |
| 02/24/2011 | US20110046352 Disease-resistant plants and method of constructing the same |
| 02/24/2011 | US20110046351 Mutant proteins and methods for selecting them |
| 02/24/2011 | US20110046350 Length-adjustable nanoscale tether for binding targets to substrates |
| 02/24/2011 | US20110046346 Biomaterial with functionalised surfaces |
| 02/24/2011 | US20110046075 Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046060 Coagulation factor IX compositions and methods of making and using same |
| 02/24/2011 | US20110046057 Uses of cerberus and derivatives thereof |
| 02/24/2011 | US20110046056 Apoa-1 peptide mimetics |
| 02/24/2011 | US20110046055 Therapeutic agent for diabetes |
| 02/24/2011 | US20110046054 Anti diabetic protein |
| 02/24/2011 | US20110046045 Method of treating obesity and metabolic disorders related to excess adipose tissue by administration of sFRP-5 peptide |
| 02/24/2011 | US20110046038 Polypeptide-Polymer Conjugates and Methods of Use Thereof |
| 02/24/2011 | US20110046000 Methods to increase the photostability of dyes |
| 02/24/2011 | US20110045605 Characterization of Granulocytic Ehrlichia and Methods of Use |
| 02/24/2011 | US20110045604 Molecular affinity clamp technology and uses thereof |
| 02/24/2011 | US20110045590 Calcium-influx inhibitory factor and method of isolation thereof |
| 02/24/2011 | US20110045572 Protein variants having modified immunogenicity |
| 02/24/2011 | US20110045549 Polynucleotides encoding a feedback resistant aspartokinase from corynebacterium |
| 02/24/2011 | US20110045529 Method and gene for providing or enhancing nonspecific adhesive property and/or autoagglutinating property for microorganisms |
| 02/24/2011 | US20110045513 Protein electron mediator |
| 02/24/2011 | US20110045501 St2-based dengue fever diagnostic |
| 02/24/2011 | US20110045491 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 02/24/2011 | US20110045488 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 02/24/2011 | US20110045487 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 02/24/2011 | US20110045098 Excitatory glycine receptors and methods |
| 02/24/2011 | US20110045061 Gene therapy for diabetic ischemic disease |
| 02/24/2011 | US20110045059 Vaccine against varicella zoster virus |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045018 Astrovirus species |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110045015 Conjugated beta-1,3-linked glucans |
| 02/24/2011 | US20110045011 TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (R56) OF ORIENTIA TSUTSUGAMUSHI STRAINS KARP, KATO and GILLIAM AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110044982 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044956 Nell-1 enhanced bone mineralization |
| 02/24/2011 | US20110044928 Microparticle film composition |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | CA2771606A1 Methods of using cd44 fusion proteins to treat cancer |
| 02/24/2011 | CA2771540A1 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 02/24/2011 | CA2771232A1 Purification of vwf for increased removal of non-lipid enveloped viruses |
| 02/24/2011 | CA2770872A1 Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
| 02/24/2011 | CA2770854A1 Functional expression of shuffled yeast nitrate transporter (ynt1) in maize to improve nitrate uptake under low nitrate environment |
| 02/24/2011 | CA2770762A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 02/24/2011 | CA2770609A1 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | CA2770438A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/24/2011 | CA2769619A1 Targeted immunoconjugates |
| 02/24/2011 | CA2769415A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/24/2011 | CA2768640A1 Apolipoprotein l-i variants and their use |
| 02/24/2011 | CA2766571A1 A preparative non-linear gradient based chromatographic method and purified products thereof |
| 02/23/2011 | EP2287618A2 Method for diagnosing neuro-degenerative disease |
| 02/23/2011 | EP2287617A2 Method for diagnosing neuro-degenerative disease |
| 02/23/2011 | EP2287337A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 02/23/2011 | EP2287326A1 Methods of protein production in yeast |
| 02/23/2011 | EP2287319A1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287315A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287314A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287313A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287312A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287311A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287310A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/23/2011 | EP2287309A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 02/23/2011 | EP2287301A2 Methods and compositions to inhibit P2X7 receptor expression |
| 02/23/2011 | EP2287300A1 Bacterial toxin vaccine |
| 02/23/2011 | EP2287296A1 Lipolytic enzyme |
| 02/23/2011 | EP2287292A2 Plant derived hydroxy phenyl pyruvate dioxygneases (HPPD) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287185A2 High affinity TCR proteins and methods |
| 02/23/2011 | EP2287184A2 Novel insulin derivatives |
| 02/23/2011 | EP2287183A1 Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287180A1 Poa p 5-derivatives with reduced allergenicity and T-cell reactivity |
| 02/23/2011 | EP2287179A2 Increased bacillus YweA expression |
| 02/23/2011 | EP2287178A2 Bacillus licheniformis YvmC inactivation |
| 02/23/2011 | EP2287177A2 Streptococcus agalactiae antigens I + II |
| 02/23/2011 | EP2287176A1 Borrelia antigens |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2286833A2 Peptides for desensibilization against allergens |
| 02/23/2011 | EP2286831A1 A method of inducing a CTL response |
| 02/23/2011 | EP2285969A1 Process, vectors and engineered cell lines for enhanced large-scale transfection |
| 02/23/2011 | EP2285952A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 02/23/2011 | EP2285832A2 Antibodies and processes for preparing the same |
| 02/23/2011 | EP2285829A1 Method of controlling a polypeptide modification reaction |
| 02/23/2011 | EP2285828A1 Polypeptides involved in the neuroregeneration-promoting properties of olfactory ensheathing glia |
| 02/23/2011 | EP2285827A1 Peptides and uses thereof |
| 02/23/2011 | EP2285826A1 Anti-angiogenic compositions and therapeutic applications thereof |
| 02/23/2011 | EP2285415A1 Anti-angiogenic compounds |
| 02/23/2011 | EP2285414A1 Fully synthetic albumin analogue |
| 02/23/2011 | EP2285399A2 Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders |
| 02/23/2011 | EP2041164B1 Improved inorganic phosphate assays |